Provided by Tiger Trade Technology Pte. Ltd.

RCN Pareto Strategic Allocation ETF

28.53
+0.23500.83%
Volume:109
Turnover:3K
Market Cap:17.89M
PE:- -
High:28.53
Open:28.43
Low:28.43
Close:28.29
52wk High:28.58
52wk Low:24.68
Shares:627.19K
Float Shares:627.19K
Volume Ratio:0.51
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
RCN Pareto Strategic Allocation ETF
Exchange:
ARCA
Establishment Date:
2026
Employees:
- -
Office Location:
234 West Florida Street,Suite 700,Milwaukee,Wisconsin,United States
Zip Code:
53204
Fax:
- -
Introduction:
Proteon Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular diseases. It develops vonapanitase, a recombinant human elastase, which is in two Phase III clinical trials in patients with chronic kidney disease undergoing surgical creation of a radiocephalic arteriovenous fistula for hemodialysis; has completed a Phase I/II clinical trials for the treatment of patients undergoing arteriovenous graft placement; and has completed Phase I clinical trial for the treatment of symptomatic peripheral artery diseases. The company was founded in 2001 and is headquartered in Waltham, Massachusetts.